Stress Management — Cost, Top Hospitals & Success Rates | MyMedicPlus

<p>Stress management encompasses a broad range of evidence-based psychological, behavioural, and pharmacological strategies designed to reduce the physiological and psychological impact of stress on the human body and mind. While acute, short-lived stress is a normal and evolutionarily adaptive response that sharpens focus and mobilises energy, <strong>chronic, unrelieved stress</strong> is a major contributor to cardiovascular disease, immune suppression, metabolic syndrome, anxiety disorders, and clinical depression.</p><p>The biological basis of the stress response lies in activation of the <strong>hypothalamic-pituitary-adrenal (HPA) axis</strong> and the <strong>sympathetic nervous system (SNS)</strong>. When the brain perceives a threat, the amygdala signals the hypothalamus to release corticotropin-releasing hormone (CRH), which drives the pituitary gland to secrete ACTH, ultimately triggering adrenal cortisol and adrenaline release. In the short term, this cascade is protective. Chronically elevated cortisol, however, damages the hippocampus (impairing memory and emotional regulation), raises blood pressure, dysregulates blood glucose, promotes visceral adiposity, suppresses immune function, and disrupts sleep architecture.</p><p>According to the <strong>American Psychological Association</strong> (2024), more than 1 in 4 adults report feeling so stressed that they are unable to function effectively on most days. The World Health Organization identifies work-related stress as a <strong>global occupational health epidemic</strong>, costing economies hundreds of billions of dollars annually in lost productivity, absenteeism, and healthcare utilisation.</p><p>Modern stress management integrates multiple evidence-based modalities. <strong>Cognitive-Behavioural Therapy (CBT)</strong> is the most extensively studied psychological intervention, helping patients identify maladaptive thought patterns and replace them with constructive cognitive frameworks. <strong>Mindfulness-Based Stress Reduction (MBSR)</strong>, developed by Jon Kabat-Zinn at the University of Massachusetts Medical School, uses structured meditation and body-scan exercises to cultivate non-judgmental present-moment awareness, consistently demonstrating reductions in perceived stress, cortisol levels, and inflammatory markers (IL-6, TNF-alpha) in randomised controlled trials.</p><p>Equally important are lifestyle interventions: regular aerobic exercise, sleep hygiene optimisation, dietary modification (Mediterranean diet pattern), social connectedness, and digital detoxing. For patients with stress-related psychiatric comorbidities, <strong>pharmacological management</strong> with selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs) may be indicated. This guide provides a comprehensive, clinically grounded overview of all major stress management approaches to support informed decision-making in partnership with a qualified healthcare provider.</p>

<p>Stress management techniques are clinically indicated across a wide spectrum of mental health, psychosomatic, and lifestyle-related conditions. Elevated chronic stress rarely exists in isolation — it typically interacts with and exacerbates multiple co-existing health problems. The following conditions are commonly addressed through structured stress management programmes:</p><h4>Primary Mental Health Conditions</h4><ul><li><strong>Generalised Anxiety Disorder (GAD):</strong> Characterised by persistent, excessive worry about everyday events; stress management reduces hyperarousal and catastrophising.</li><li><strong>Major Depressive Disorder (MDD):</strong> Chronic stress is a primary precipitant of depression; CBT and MBSR demonstrate comparable efficacy to antidepressants in mild-to-moderate MDD.</li><li><strong>Burnout Syndrome (ICD-11 Z73.0):</strong> Occupational burnout defined by emotional exhaustion, depersonalisation, and reduced personal accomplishment; requires both individual and workplace-level interventions.</li><li><strong>Post-Traumatic Stress Disorder (PTSD):</strong> Trauma-Focused CBT and EMDR are evidence-based; general stress management supports symptom regulation.</li><li><strong>Adjustment Disorder:</strong> Maladaptive response to identifiable stressors; typically resolves within 6 months with structured support and brief therapy.</li><li><strong>Insomnia Disorder:</strong> Stress is the most common precipitating factor; Cognitive-Behavioural Therapy for Insomnia (CBT-I) is the first-line treatment.</li></ul><h4>Psychosomatic and Physical Conditions</h4><ul><li><strong>Stress-Related Hypertension:</strong> Chronic sympathetic activation raises systemic vascular resistance; relaxation techniques reduce systolic BP by 5–10 mmHg on average.</li><li><strong>Irritable Bowel Syndrome (IBS):</strong> The gut-brain axis means psychological stress directly modulates gut motility and pain perception; gut-directed hypnotherapy and CBT are evidence-based treatments.</li><li><strong>Tension-Type Headaches and Migraine:</strong> Stress is the most commonly reported migraine trigger; relaxation-based therapies reduce frequency by 30–50%.</li><li><strong>Chronic Pain Conditions:</strong> Psychological stress amplifies pain perception through central sensitisation; multidisciplinary pain programmes incorporating stress management improve function and quality of life.</li><li><strong>Immune Dysregulation:</strong> Chronic stress suppresses natural killer cell activity and impairs vaccine response; stress management interventions restore immune competence.</li><li><strong>Type 2 Diabetes Management:</strong> Cortisol-driven insulin resistance worsens glycaemic control; stress management improves HbA1c in some studies.</li></ul><p>Additionally, stress management is beneficial for <strong>caregiver burnout</strong>, <strong>academic and examination stress</strong> in students, <strong>cancer patients</strong> (psycho-oncology support), and individuals experiencing <strong>bereavement or major life transitions</strong>. The bidirectional relationship between stress and physical health makes stress management an integral component of comprehensive chronic disease management.</p>

<p>Virtually all adults experiencing elevated psychological stress can benefit from some form of stress management, though the appropriate level and intensity of intervention depends on the severity and nature of the stress response. <strong>Formal eligibility criteria</strong> are used to match patients to the most suitable programme or therapy.</p><h4>Assessment Tools Used to Determine Eligibility</h4><ul><li><strong>Perceived Stress Scale (PSS-10):</strong> A 10-item validated questionnaire measuring subjective perceived stress over the past month. Scores 14–26 indicate moderate stress; 27+ indicates severe stress.</li><li><strong>GAD-7:</strong> Generalised Anxiety Disorder 7-item scale; scores ≥10 warrant further evaluation and treatment.</li><li><strong>PHQ-9:</strong> Patient Health Questionnaire for depression; identifies stress-driven depressive episodes requiring targeted intervention.</li><li><strong>Maslach Burnout Inventory (MBI):</strong> Specifically validated for occupational burnout in healthcare, education, and other professions.</li></ul><h4>Eligibility by Intervention Level</h4><ul><li><strong>Mild stress (PSS-10 < 14):</strong> Self-directed interventions — digital apps (Headspace, Calm), exercise programmes, psychoeducation resources, workplace wellness initiatives.</li><li><strong>Moderate stress (PSS-10 14–26):</strong> Structured psychotherapy (CBT, MBSR), group therapy programmes, Employee Assistance Programme counselling, pharmacotherapy review by GP.</li><li><strong>Severe stress with psychiatric comorbidity (PSS-10 > 27 + PHQ-9 > 10 or GAD-7 > 10):</strong> Psychiatric evaluation, combination of pharmacotherapy and psychotherapy, possible short-term inpatient or day programme support.</li></ul><h4>Special Populations</h4><ul><li><strong>Pregnant women:</strong> Mindfulness-based interventions and CBT are preferred; pharmacological options are limited and require specialist review.</li><li><strong>Older adults:</strong> Benefit from relaxation techniques and social engagement programmes; benzodiazepines are generally contraindicated due to fall and cognitive risks.</li><li><strong>Adolescents and young adults:</strong> School-based CBT programmes and digital mental health platforms are effective; parental and school system involvement enhances outcomes.</li><li><strong>Healthcare workers:</strong> A high-risk group requiring both individual therapy and systemic workplace changes; peer support programmes are particularly effective.</li></ul><p>There are very few absolute contraindications to stress management. However, patients with <strong>active psychosis, severe personality disorders, or active suicidal ideation</strong> require psychiatric stabilisation before commencing group-based stress management programmes. Patients with uncontrolled medical conditions (e.g., severe hypertension, cardiac disease) should obtain medical clearance before commencing intensive exercise-based stress management.</p>

<p>Stress management draws on a rich evidence base of psychological, pharmacological, and lifestyle interventions. Effective treatment is typically <strong>multimodal</strong>, combining approaches from different categories based on the patient's clinical presentation, preferences, and resources.</p><h4>Psychological Therapies</h4><ul><li><strong>Cognitive-Behavioural Therapy (CBT):</strong> The gold-standard psychological intervention (8–20 structured sessions). CBT identifies and restructures negative automatic thoughts, catastrophising, and maladaptive coping behaviours. Delivered individually or in groups; also available via validated online platforms (iCBT).</li><li><strong>Mindfulness-Based Stress Reduction (MBSR):</strong> Jon Kabat-Zinn’s 8-week structured group programme (2.5 hours/week) combining formal sitting meditation, body scan, gentle yoga, and mindful movement. Meta-analyses demonstrate significant reductions in stress, anxiety, and depression.</li><li><strong>Acceptance and Commitment Therapy (ACT):</strong> Helps patients develop psychological flexibility by accepting distressing thoughts without over-identification and committing to values-based actions.</li><li><strong>CBT for Insomnia (CBT-I):</strong> First-line treatment for stress-related insomnia; more effective than sleep medications long-term. Includes sleep restriction, stimulus control, and sleep hygiene.</li></ul><h4>Lifestyle and Behavioural Interventions</h4><ul><li><strong>Aerobic Exercise:</strong> WHO guidelines recommend 150–300 minutes/week of moderate-intensity activity. Exercise reduces cortisol, raises endorphins and BDNF, improves sleep, and has antidepressant effects comparable to SSRIs in mild-to-moderate depression.</li><li><strong>Sleep Hygiene Optimisation:</strong> Consistent sleep schedule, dark and cool bedroom, no screens 1 hour before bed, limiting caffeine after 2 pm, and relaxation routines.</li><li><strong>Dietary Modification:</strong> Mediterranean diet pattern (rich in omega-3s, polyphenols, whole grains) is associated with lower stress and depression risk. Reducing ultra-processed foods, refined sugars, and excessive caffeine reduces stress reactivity.</li></ul><h4>Biofeedback and Technology</h4><ul><li><strong>Heart Rate Variability (HRV) Biofeedback:</strong> Teaches patients to voluntarily increase HRV (a marker of autonomic resilience) through slow breathing (5–6 breaths/minute). Devices include EmWave2 (HeartMath) and wearable monitors.</li><li><strong>Digital Therapeutics:</strong> Clinically validated apps including Calm, Headspace, Woebot (AI-based CBT), and Wysa have demonstrated efficacy for mild-to-moderate stress in large population studies.</li></ul><h4>Pharmacological Treatment</h4><ul><li><strong>SSRIs:</strong> Escitalopram, sertraline, and fluoxetine are first-line for stress-related anxiety disorders and depression; typically commenced at low dose and titrated over 2–4 weeks. Full therapeutic effect at 4–8 weeks.</li><li><strong>SNRIs:</strong> Venlafaxine and duloxetine are effective for stress-related anxiety with somatic symptoms (pain, fatigue).</li><li><strong>Buspirone:</strong> Non-habit-forming anxiolytic for GAD; takes 2–4 weeks for onset.</li><li><strong>Short-term Benzodiazepines:</strong> Restricted to acute crisis situations (e.g., lorazepam); maximum 2–4 weeks to avoid dependence; generally avoided in elderly patients.</li></ul>

<p>A robust and expanding evidence base demonstrates that structured stress management interventions produce clinically meaningful improvements across psychological, physiological, and social domains. The following summarises key evidence-based benefits:</p><h4>Psychological Benefits</h4><ul><li><strong>Reduced Perceived Stress:</strong> CBT reduces PSS-10 scores by an average of 6–8 points — equivalent to moving from ‘high stress’ to ‘moderate’ or ‘low’ classification. MBSR demonstrates comparable results, particularly in healthcare worker populations.</li><li><strong>Anxiety Reduction:</strong> Meta-analyses of CBT show large effect sizes (Cohen’s d 0.8–1.0) for anxiety reduction, with effects maintained at 12-month follow-up.</li><li><strong>Depression Prevention and Treatment:</strong> Regular mindfulness practice reduces relapse rates in recurrent depression by ~50% (equivalent to maintenance antidepressants).</li><li><strong>Improved Sleep Quality:</strong> CBT-I improves the Pittsburgh Sleep Quality Index (PSQI) score by 3–5 points and increases sleep efficiency from approximately 70% to 90%.</li><li><strong>Cognitive Performance:</strong> Reduced cortisol preserves hippocampal volume, improving working memory, concentration, and executive function.</li></ul><h4>Physiological Benefits</h4><ul><li><strong>Cortisol Normalisation:</strong> MBSR reduces morning salivary cortisol by 15–25% after 8 weeks. Exercise reduces evening cortisol and blunts the acute stress response over time.</li><li><strong>Cardiovascular Health:</strong> Relaxation-based interventions reduce systolic blood pressure by 5–10 mmHg on average. Improved HRV (a measure of parasympathetic tone) is associated with lower cardiovascular event risk.</li><li><strong>Immune Function Enhancement:</strong> Mindfulness training increases natural killer (NK) cell activity and telomerase activity (a marker of cellular ageing) and reduces pro-inflammatory cytokines including IL-6 and TNF-alpha.</li><li><strong>Metabolic Improvements:</strong> Reduced cortisol decreases visceral adiposity and improves insulin sensitivity, contributing to better glycaemic control in type 2 diabetes.</li></ul><h4>Occupational and Social Benefits</h4><ul><li><strong>Reduced Absenteeism:</strong> Workplace Employee Assistance Programmes (EAPs) incorporating stress management reduce absenteeism by 25–50% in participating employees.</li><li><strong>Improved Work Performance and Presenteeism:</strong> Lower stress levels improve decision-making, creativity, and interpersonal effectiveness.</li><li><strong>Better Quality of Life:</strong> SF-36 quality-of-life scores improve significantly in patients completing structured CBT or MBSR programmes.</li></ul><p>The benefits of stress management extend beyond individual wellbeing to significant <strong>healthcare cost savings</strong>. Studies estimate that every $1 invested in evidence-based workplace mental health programmes yields a $4–5 return through reduced absenteeism and productivity gains (Harvard Business Review analysis, 2024).</p>

<p>Stress management interventions are generally safe, but patients should be aware of potential risks associated with both psychological therapies and pharmacological treatments. Understanding these risks enables informed consent and appropriate monitoring.</p><h4>Psychological Therapy Risks</h4><ul><li><strong>Emotional Distress During Therapy:</strong> Exploring stressful events in CBT or trauma-focused therapies can temporarily intensify negative emotions. This is expected and typically resolves as therapy progresses, but requires a skilled therapist to manage safely.</li><li><strong>MBSR in Severe PTSD:</strong> Mindfulness meditation can occasionally intensify dissociation or flashbacks in patients with severe, unprocessed trauma. Careful screening and trauma-informed adaptations (e.g., trauma-sensitive mindfulness) are recommended.</li><li><strong>Premature Termination:</strong> Dropping out of therapy before completion reduces efficacy and can reinforce avoidant coping. Adequate therapeutic alliance and psychoeducation about the treatment process reduce dropout rates.</li></ul><h4>Pharmacological Risks</h4><ul><li><strong>SSRI/SNRI Side Effects:</strong> Common initial side effects include nausea, headache, insomnia, agitation, and reduced libido. Most resolve within 2–4 weeks. Sexual dysfunction (reduced libido, delayed orgasm) may persist and requires management discussion.</li><li><strong>SSRI Discontinuation Syndrome:</strong> Abrupt cessation causes dizziness, electric shock sensations (‘brain zaps’), irritability, and flu-like symptoms. Always taper slowly under medical supervision.</li><li><strong>Benzodiazepine Dependence:</strong> Even short-term use (2–4 weeks) can cause physiological dependence. Associated with cognitive impairment, rebound anxiety on cessation, and increased fall risk in older adults. Generally avoided as long-term treatment.</li><li><strong>Increased Suicidal Ideation (SSRIs in adolescents):</strong> FDA black-box warning for patients under 25 starting SSRIs; requires close monitoring in the first 4 weeks of treatment.</li></ul><h4>Lifestyle Intervention Risks</h4><ul><li><strong>Exercise Overtraining Syndrome:</strong> Excessive exercise without adequate recovery paradoxically elevates cortisol. A balanced programme with rest days is essential.</li><li><strong>Herbal Supplement Interactions:</strong> Adaptogens such as ashwagandha and St John’s Wort can interact with medications; St John’s Wort is a potent CYP3A4 inducer reducing efficacy of many drugs including oral contraceptives and anticoagulants. Always disclose supplement use to your healthcare provider.</li><li><strong>Digital App Limitations:</strong> App-based interventions are insufficient for moderate-to-severe psychiatric conditions and should not substitute for clinical care.</li></ul><p>Overall, the <strong>risk-to-benefit ratio</strong> for evidence-based stress management is highly favourable. Serious adverse events from psychological therapies are rare. Pharmacological risks can be mitigated through appropriate prescribing, patient education, and regular monitoring. Discuss any concerns with your prescribing physician or therapist before commencing or discontinuing treatment.</p>

<p>Effective stress management requires a structured, ongoing follow-up plan to monitor progress, adjust interventions as needed, support relapse prevention, and maintain long-term gains. Stress management is rarely a one-time intervention; it is a set of skills and habits that must be cultivated and reinforced over time.</p><h4>During Active Treatment</h4><ul><li><strong>Weekly Therapy Sessions (CBT/ACT):</strong> Typically 8–20 sessions, reviewed every 4–6 weeks using validated scales (PSS-10, PHQ-9, GAD-7) to track progress and adapt treatment if insufficient response is observed.</li><li><strong>Stress Diary Monitoring:</strong> Patients record daily stressors, thoughts, physical symptoms, and coping strategies to identify patterns and triggers between sessions.</li><li><strong>Pharmacotherapy Review:</strong> GP or psychiatrist review at 2, 4, and 8 weeks after starting SSRIs to assess efficacy, tolerability, and safety (especially in under-25s).</li></ul><h4>Post-Treatment Maintenance</h4><ul><li><strong>Booster CBT Sessions:</strong> 1–2 ‘booster’ sessions at 3 and 6 months post-treatment significantly reduce relapse rates and consolidate skills learned during therapy.</li><li><strong>Daily Mindfulness Practice:</strong> Research recommends 20–30 minutes of formal mindfulness practice daily for maintenance of stress reduction benefits. Brief informal practices (mindful breathing, body scans) can be integrated throughout the day.</li><li><strong>GP Annual Review:</strong> Annual holistic health review including mental health screening, blood pressure monitoring (stress-related hypertension), and lifestyle assessment.</li></ul><h4>Relapse Prevention Planning</h4><ul><li><strong>Identify Personal Triggers:</strong> Work with your therapist to map your specific stress triggers (workplace, relationship, financial, health-related) and plan evidence-based coping responses in advance.</li><li><strong>Early Warning Signs:</strong> Recognise personal early warning signs of stress escalation (sleep changes, irritability, muscle tension) and have a crisis plan including who to contact and which coping tools to use.</li><li><strong>Social Support Network:</strong> Active maintenance of supportive relationships; peer support groups or alumni MBSR groups sustain long-term wellbeing.</li></ul><p>For patients on long-term pharmacotherapy, ongoing prescribing reviews should assess the continued need for medication, manage any persistent side effects, and plan for eventual tapering if clinically appropriate. The combination of psychological maintenance strategies with appropriate pharmacotherapy generally produces the best long-term outcomes.</p>

<p>The cost of stress management varies enormously depending on the type of intervention, healthcare system, geographic location, and whether care is subsidised by insurance, employer programmes, or government schemes. Understanding the cost landscape helps patients plan access to appropriate care.</p><h4>Psychological Therapy Costs</h4><ul><li><strong>Individual CBT (United States):</strong> $100–$250 per session out-of-pocket; with insurance, $20–$60 co-pay. A full 12-session course costs $1,200–$3,000 without insurance.</li><li><strong>Individual CBT (United Kingdom):</strong> Free via NHS IAPT (Improving Access to Psychological Therapies) for moderate presentations; private CBT £60–£120/session.</li><li><strong>Group CBT or MBSR Programmes:</strong> Significantly more affordable; group CBT $30–$80/session; MBSR 8-week programme $300–$600 total at university medical centres.</li><li><strong>Online CBT Platforms (iCBT):</strong> Platforms such as SilverCloud, This Way Up, and MoodGym offer clinically validated online CBT for $30–$150 for full courses, significantly expanding access.</li></ul><h4>Pharmacological Costs</h4><ul><li><strong>Generic SSRIs:</strong> Generic escitalopram or sertraline $5–$20/month in the US via discount programmes (GoodRx); $2–8/month in India and Southeast Asia.</li><li><strong>Brand SSRIs:</strong> Without insurance, $150–$300/month in the US; mostly unnecessary given generic bioequivalence.</li><li><strong>Psychiatric Evaluation:</strong> Initial assessment $200–$500 (US), $150–$300 (Australia), £100–£250 (UK private); follow-up consultations $100–$200.</li></ul><h4>Low-Cost and Free Options</h4><ul><li><strong>Employee Assistance Programmes (EAPs):</strong> Most large employers provide 3–8 free confidential counselling sessions per year. Access via HR department.</li><li><strong>Digital Apps (Free Tier):</strong> Woebot, Wysa, and NHS-approved apps (Everymind at Home, Sleepio) offer substantial free content. Premium plans range $0–$70/year (Headspace, Calm).</li><li><strong>Aerobic Exercise:</strong> One of the most cost-effective stress reduction tools available; free outdoor exercise (walking, running) incurs no cost. Community gym memberships range from $20–$60/month.</li><li><strong>Community and Peer Support:</strong> Support groups, community mindfulness classes, and faith-based programmes often free or donation-based.</li></ul><p>For patients in lower-income settings or countries, <strong>task-shifting models</strong> (mental health support delivered by trained community health workers) and <strong>telehealth platforms</strong> significantly reduce access barriers. MyMedicPlus can help connect patients with cost-effective stress management resources internationally.</p>

<p>A range of complementary and integrative therapies can support conventional stress management programmes. While few meet the rigorous evidence standards of CBT or MBSR, several demonstrate meaningful clinical benefits in well-designed studies and can serve as valuable adjuncts — or as primary interventions for patients with mild-to-moderate stress who prefer non-pharmacological, non-Western approaches.</p><h4>Mind-Body Practices</h4><ul><li><strong>Yoga (Hatha, Vinyasa, Kundalini):</strong> Multiple randomised controlled trials demonstrate that yoga reduces perceived stress, anxiety, and depression scores. A 2023 meta-analysis in <em>JAMA Network Open</em> found yoga comparable to CBT for mild-to-moderate anxiety. Yoga also improves sleep quality, HRV, and cortisol profiles.</li><li><strong>Tai Chi and Qigong:</strong> These ancient Chinese movement practices activate the parasympathetic nervous system through slow, meditative movement and breath control. Evidence supports their efficacy for reducing anxiety, blood pressure, and stress in older adults particularly.</li><li><strong>Progressive Muscle Relaxation (PMR):</strong> Edmund Jacobson’s systematic technique of tensing and releasing muscle groups promotes body awareness and physical release of tension. Effective as a self-administered nightly relaxation practice; reduces physiological arousal and improves sleep.</li></ul><h4>Acupuncture and Traditional Medicine</h4><ul><li><strong>Acupuncture:</strong> Cochrane reviews and systematic analyses report moderate evidence supporting acupuncture for stress-related anxiety, insomnia, and chronic pain. Proposed mechanisms include endorphin release, autonomic regulation, and neuroinflammation modulation.</li><li><strong>Ayurvedic Approaches:</strong> Ashwagandha (Withania somnifera) has robust RCT evidence for cortisol reduction and stress relief (KSM-66 extract reduces cortisol by 27.9% vs placebo in a 60-day trial). Brahmi (Bacopa monnieri) supports cognitive resilience. Always discuss herbal supplements with your doctor before use.</li></ul><h4>Environmental and Social Interventions</h4><ul><li><strong>Nature Therapy (Ecotherapy / Forest Bathing):</strong> Japanese Shinrin-yoku (‘forest bathing’) involves spending structured time in forested environments. Studies demonstrate significant reductions in cortisol, blood pressure, and NK cell activity improvements after 2-hour sessions.</li><li><strong>Journaling and Expressive Writing:</strong> Pennebaker’s expressive writing paradigm (20 minutes of structured emotional writing for 3–4 consecutive days) reduces psychological distress and improves immune function in randomised studies.</li><li><strong>Social Prescribing:</strong> Connecting patients with community groups, arts programmes, volunteering, and social activities addresses social determinants of stress. UK NHS social prescribing link workers have demonstrated significant reductions in GP visit frequency and mental distress scores.</li></ul><p>It is important that complementary approaches are used <strong>in addition to, not instead of</strong>, evidence-based care for moderate or severe stress-related conditions. Always inform your healthcare provider about all complementary therapies you are using to ensure safe integration with any concurrent medical treatments.</p>